Ebola chimpanzee adenovirus vector vaccine (cAd3-EBO)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ebola chimpanzee adenovirus vector vaccine (cAd3-EBO), covering 2018-07-05 to 2018-07-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults [Phase 1]